Typhim VI 25 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM2ZN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,590
Award facts
- Contract value 100% obligated
- $63,590.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $63,590.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on January 23, 2026, with a completion date of January 26, 2026. This contract is a non-set-aside award, competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
TYPHIM VI is a typhoid vaccine product supplied through the military medical supply chain to support Department of Defense healthcare requirements. AmerisourceBergen, operating as a subsidiary of Cencora, Inc., maintains a critical role as a pharmaceutical prime vendor for federal medical procurement, particularly serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical and medical commodity requirements across multiple therapeutic domains through open competition and firm fixed-price arrangements.
Quick answers
Who was awarded contract SPE2DR26FM2ZN?
SPE2DR26FM2ZN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FM2ZN worth?
The government has obligated $63,590 on SPE2DR26FM2ZN.
Is contract SPE2DR26FM2ZN an order under another contract?
Yes. SPE2DR26FM2ZN is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM2ZN competed?
The extent of competition for SPE2DR26FM2ZN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award